---
---

@article{sondermann_diabetes_2020,
	title = {Diabetes {Mellitus} and {Hypertension}—{A} {Case} of {Sugar} and {Salt}?},
	volume = {21},
	doi = {10.3390/ijms21155200},
	number = {15},
	journal = {International Journal of Molecular Sciences},
	author = {Sondermann, Marcus and Holecki, Micha{\textbackslash}l and Kirsch, Andrea Marita and Bastian, Manuela and Fischer, Dagmar-Christiane and Willenberg, Holger Sven},
	month = jul,
	year = {2020},
	note = {Publisher: MDPI AG},
	pages = {5200},
	annote = {Anmerkungen herauskopieren (8.5.2021, 16:20:06)"sed so far, including overactivity of the sympathetic nervous and the renin-angiotensin-aldosterone systems (RAAS), aberrant renal sodium handling, endothelial dysfunction, blood vessel damage, insulin resistance, chronic inflammation, and activation of adrenal steroid hormone secretion" (Sondermann et al 2020:5200)"blood concentrations of glucose and sodium are also increased via hormonal mechanisms involving the adrenal gland and secretion of glucocorticoids and/or mineralocorticoids and bind to their respective receptor" (Sondermann et al 2020:5200)"Glucose and sodium bind water, raise the osmotic pressure, idney." (Sondermann et al 2020:5200)"Hypervolemia develops, disguising the total body content of glucose and sodium, and promotes theely high." (Sondermann et al 2020:5201)"plasma osmolality values higher than 300 mosmol/kg, whereby half of them were in the group of individuals with elevated glucose concentrations after the oral glucose challenge" (Sondermann et al 2020:5202)"elevant correlation between plasma osmolality and serum copeptin concentrationsn" (Sondermann et al 2020:5202)"(8.40 [7.65-9.05] \% vs. 7.25 [6.40-8.05] \%; p {\textless} 0.001). In 10 of these patientsc data on serum N-terminal brain natriuretic peptide (NT-proBNP) concene" (Sondermann et al 2020:5202)"trations obtained prior ande after improved glucose metabolism by the modified insulin therapy revealed a nonsignificantc increase of NT-proBNP, in parallel to the intensification of insulin therapy (102 [59.2-260.2] vs. 12g" (Sondermann et al 2020:5202)"In 10 of these patients, data on serum N-terminal brain natriuretic peptide (NT-proBNP) concentrations obtained prior and after improved glucose metabolism by the modified insulin therapy revealed a nonsignificant increase of NT-proBNP, in parallel to the intensification of insulin therapy (102 [59.2-260.2] vs. 123 [57.8-278.5] ng/mL). Concentrations of the NT-proBNP, however, were lower the more HbA1c dropped after intervention (Figure 2, Panels b-d)." (Sondermann et al 2020:5203)"RAAS activation as a consequence of surplus adipose tissue and a long list of factors generated by these fat cells [4-8,10]." (Sondermann et al 2020:5203)"multiple studies have shown that a salt-mediated increase in osmolality triggers the release of arginine-vasopressin [13,14]." (Sondermann et al 2020:5203)"Our data on osmolality and copeptin reflect this relationship and the dose-response curve is similar to the one reviewed recently [15]." (Sondermann et al 2020:5203)"he action of vasopressin, and is reflected by blood pressure, copeptin, and NT-proBNP levels [10,23]." (Sondermann et al 2020:5203)"regulation of glucose concentrations by cortisol has many aspects in common with the regulation of sodium concentrations by aldosterone. Both sugar and salt regulate blood osmolality, which triggers thirst as well as copeptin/vasopressin release and which is related to blood pressure. Through reabsorption of sugar and salt in the kidney, elevations in plasma glucose concentrations promote sodium retention and elevations in NT-proBNP, most likely by fluid load. Thus, DM is probably a sodium retention disorder with all its negative consequences." (Sondermann et al 2020:5205)},
	file = {Sondermann et al. - 2020 - Diabetes Mellitus and Hypertension—A Case of Sugar and Salt 1.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Endokrinologie/Sondermann et al. - 2020 - Diabetes Mellitus and Hypertension—A Case of Sugar and Salt 1.pdf:application/pdf;Sondermann et al. - 2020 - Diabetes Mellitus and Hypertension—A Case of Sugar and Salt 2.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Endokrinologie/Sondermann et al. - 2020 - Diabetes Mellitus and Hypertension—A Case of Sugar and Salt 2.pdf:application/pdf;Sondermann et al. - 2020 - Diabetes Mellitus and Hypertension—A Case of Sugar and Salt.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Endokrinologie/Sondermann et al. - 2020 - Diabetes Mellitus and Hypertension—A Case of Sugar and Salt.pdf:application/pdf},
}

@article{enzmann_transrektale_2021,
	title = {Der transrektale {Ultraschall} ({TRUS}) in der urologischen {Praxis}},
	doi = {10.1007/s41972-021-00128-8},
	journal = {Journal für Urologie und Urogynäkologie/Österreich},
	author = {Enzmann, Thomas and Sondermann, Marcus},
	month = feb,
	year = {2021},
	note = {Publisher: Springer Science and Business Media LLC},
	file = {Enzmann und Sondermann - 2021 - Der transrektale Ultraschall (TRUS) in der urologischen Praxis.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Urologie/Tumore/Prostata/Prostatastanzbiopsie/Enzmann und Sondermann - 2021 - Der transrektale Ultraschall (TRUS) in der urologischen Praxis.pdf:application/pdf},
}

@article{sondermann_nichtinsuline_2019,
	title = {Nichtinsuline bei {Diabetes} mellitus {Typ} 1},
	volume = {14},
	copyright = {All rights reserved},
	issn = {18618413},
	journal = {Kompendium Diabetes},
	author = {Sondermann, Marcus and Willenberg, Holger Sven;},
	year = {2019},
	keywords = {⛔ No DOI found},
	pages = {17--24},
}

@phdthesis{sondermann_zusammenhang_2021,
	address = {Rostock},
	title = {Der {Zusammenhang} von {Diabetes} mellitus und {Hypertonie} im {Sinne} einer chronischen {Hypervolämie} - eine prospektive {Interventionsstudie} nach hyperglykämischer {Stoffwechsellage} bei {Patienten} mit {Diabetes} mellitus},
	copyright = {All rights reserved},
	language = {Deutsch},
	school = {Rostock},
	author = {Sondermann, Marcus},
	year = {2021},
	file = {Sondermann - 2021 - Der Zusammenhang von Diabetes mellitus und Hypertonie im Sinne einer chronischen Hypervolämie - eine.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Sondermann - 2021 - Der Zusammenhang von Diabetes mellitus und Hypertonie im Sinne einer chronischen Hypervolämie - eine.pdf:application/pdf},
}

@article{sondermann_ductus-bellini-karzinom_2022,
	title = {Das {Ductus}-{Bellini}-{Karzinom}},
	issn = {0340-2592, 1433-0563},
	url = {https://link.springer.com/10.1007/s00120-022-01830-7},
	doi = {10.1007/s00120-022-01830-7},
	language = {de},
	urldate = {2022-04-24},
	journal = {Der Urologe},
	author = {Sondermann, Marcus and Günther, Marlis and Enzmann, Thomas},
	month = apr,
	year = {2022},
	keywords = {Notero},
	file = {Sondermann et al. - 2022 - Das Ductus-Bellini-Karzinom.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Urologie/Tumore/Niere/Ductus Bellini/Sondermann et al. - 2022 - Das Ductus-Bellini-Karzinom.pdf:application/pdf},
}

@article{wolff_patients_2023,
	title = {Patient’s {Desire} and {Real} {Availability} {Concerning} {Supportive} {Measures} {Accompanying} {Radical} {Prostatectomy}: {Differences} between {Certified} {Prostate} {Cancer} {Centers} and {Non}-{Certified} {Centers} {Based} on {Patient}-{Reported} {Outcomes} within the {Cross}-{Sectional} {Study} {Improve}},
	volume = {15},
	copyright = {All rights reserved},
	issn = {2072-6694},
	shorttitle = {Patient’s {Desire} and {Real} {Availability} {Concerning} {Supportive} {Measures} {Accompanying} {Radical} {Prostatectomy}},
	url = {https://www.mdpi.com/2072-6694/15/10/2830},
	doi = {10.3390/cancers15102830},
	abstract = {Certification as a prostate cancer center requires the offer of several supportive measures to patients undergoing radical prostatectomy (RP). However, it remains unclear how patients estimate the relevance of these measures and whether the availability of these measures differs between certified prostate cancer centers (CERTs) and non-certified centers (NCERTs). In 20 German urologic centers, a survey comprising questions on the relevance of 15 supportive measures was sent to 1000 patients at a median of 15 months after RP. Additionally, patients were asked to rate the availability of these measures using a four-item Likert scale. The aim of this study was to compare these ratings between CERTs and NCERTs. The response rate was 75.0\%. In total, 480 patients underwent surgery in CERTs, and 270 in NCERTs. Patients rated 6/15 supportive measures as very relevant: preoperative medical counselling concerning treatment options, a preoperative briefing answering last questions, preoperative pelvic floor exercises (PFEs), postoperative PFEs, postoperative social support, and postoperative rehabilitation addressing physical fitness recovery. These ratings showed no significant difference between CERTs and NCERTs (p = 0.133–0.676). In addition, 4/9 of the remaining criteria were rated as more detailed by patients in CERTs. IMPROVE represents the first study worldwide to evaluate a patient-reported assessment of the supportive measures accompanying RP. Pertinent offers vary marginally between CERTs and NCERTs.},
	language = {en},
	number = {10},
	urldate = {2023-11-01},
	journal = {Cancers},
	author = {Wolff, Ingmar and Burchardt, Martin and Peter, Julia and Thomas, Christian and Sikic, Danijel and Fiebig, Christian and Promnitz, Sören and Hoschke, Bernd and Burger, Maximilian and Schnabel, Marco J. and Gilfrich, Christian and Löbig, Niklas and Harke, Nina N. and Distler, Florian A. and May, Matthias},
	month = may,
	year = {2023},
	pages = {2830},
	file = {Wolff et al. - 2023 - Patient’s Desire and Real Availability Concerning Supportive Measures Accompanying Radical Prostatec.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Urologie/Tumore/Prostata/Wolff et al. - 2023 - Patient’s Desire and Real Availability Concerning Supportive Measures Accompanying Radical Prostatec.pdf:application/pdf},
}

@article{sondermann_aktuelle_2024,
	title = {Aktuelle {Behandlungsstrategien} des einfachen {Maldesenzus} testis},
	volume = {2024},
	copyright = {All rights reserved},
	issn = {1869-6619},
	url = {https://uroforum.de/aktuelle-behandlungsstrategien-des-einfachen-maldesenzus-testis/},
	abstract = {Ein unbehandelter Maldeszensus testis kann zu verschiedenen Komplikationen führen, darunter eine vermin- derte Fruchtbarkeit und ein erhöhtes Risiko für Hodentumore. Durch eine passende und rechtzeitige Behand- lung lässt sich das Risiko für diese Folgeerkrankungen reduzieren.},
	language = {de},
	number = {1},
	journal = {UroForum},
	author = {Sondermann, Marcus and Boehm, Katharin},
	month = jan,
	year = {2024},
	pages = {22--25},
	file = {Sondermann und Boehm - 2024 - Aktuelle Behandlungsstrategien des einfachen Maldesenzus testis.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Sondermann und Boehm - 2024 - Aktuelle Behandlungsstrategien des einfachen Maldesenzus testis.pdf:application/pdf},
}

@article{sondermann_zusammenhang_2021-1,
	title = {Zusammenhang von {Diabetes} mellitus und {Hypertonie} im {Sinne} einer chronischen {Hypervolämie}},
	copyright = {All rights reserved},
	url = {https://rosdok.uni-rostock.de/resolve/id/rosdok_disshab_0000003129},
	doi = {10.18453/ROSDOK_ID00004566},
	abstract = {In dieser Interventionsstudie wurden 24 Patienten einer Therapie zugeführt. Es wurden die Körpervolumina und Laborparameter gemessen. Hierbei konnte der HbA1c um 0,65 \% gesenkt werden. Die Hypertonie konnte jedoch nicht gesenkt werden. Das extrazelluläre Volumen und das NT-proBNP sanken, wenn auch nicht signifikant, leicht. Es zeigten sich auch Zusammenhänge zwischen der Osmolalität und dem Copeptin und der Osmolalität und dem systolischen Blutdruck. Aufgrund der Komplexität der Stoffwechselkreise konnte ein Zusammenhang zwischen Hypervolämie und einer Hypertonie nicht bestätigt werden.},
	language = {de},
	urldate = {2024-04-21},
	author = {Sondermann, Marcus},
	year = {2021},
	note = {Publisher: [object Object]},
	keywords = {610 Medical sciences Medicine},
}

@article{sondermann_treatment_2024,
	title = {Treatment trends for undescended testis and impact of guideline changes a medical health care analysis of orchidopexy and cryptorchidism in {Germany} between 2006 und 2020},
	volume = {42},
	copyright = {All rights reserved},
	issn = {1433-8726},
	url = {https://link.springer.com/10.1007/s00345-024-05095-x},
	doi = {10.1007/s00345-024-05095-x},
	abstract = {Abstract

              Background
              The last decades revealed new scientific knowledge regarding the fertility and potential malignancy of undescended testis AQ2(UDT). Accordingly, many guidelines changed their recommendation concerning timing of therapy, with the goal of an earlier time of surgery.


              Methods
              We analyzed the number of new diagnosis and performed surgeries in predefined age groups provided by the obligatory annual reports of German hospitals in the reimbursement.INFO”-tool between 2006 and 2020.


              Results
              Overall, 124,741 cases were analyzed. We showed a slight increase in performed surgeries in the first year by 2\% per year with a main increase till 2011, a constant number of surgeries between first and 4th year and a decrease of surgeries between 5 and 14th year of living with a main decrease till 2009 by 3\% per year.


              Conclusion
              Even if our results illustrate an increasing adaption of the guideline’s recommendation, there is still a significant number of patients who receive later treatment. More research about the reasons and circumstances for the latter is needed.},
	language = {en},
	number = {1},
	urldate = {2024-06-28},
	journal = {World Journal of Urology},
	author = {Sondermann, Marcus and Menzel, Viktoria and Borkowetz, Angelika and Baunacke, Martin and Huber, Johannes and Eisenmenger, Nicole and Thomas, Christian and Boehm, Katharina},
	month = jun,
	year = {2024},
	pages = {386},
	file = {Sondermann et al. - 2024 - Treatment trends for undescended testis and impact of guideline changes a medical health care analys.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Urologie/Kinderurologie/Kryptorchismus/Sondermann et al. - 2024 - Treatment trends for undescended testis and impact of guideline changes a medical health care analys.pdf:application/pdf},
}

@article{sondermann_aktuelle_2024-1,
	title = {Aktuelle {Behandlungsstrategien} des einfachen {Maldeszensus} testis},
	volume = {102/1},
	copyright = {All rights reserved},
	url = {https://paediatrische-praxis.info/paediatrie/aktuelle-behandlungsstrategien-des-einfachen-maldeszensus-testis/},
	journal = {pädiatrische praxis 102},
	author = {Sondermann, Marcus and Boehm, Katharin},
	month = oct,
	year = {2024},
	pages = {88--94},
	file = {Sondermann und Boehm - 2024 - Aktuelle Behandlungsstrategien des einfachen Maldeszensus testis.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Urologie/Kinderurologie/Kryptorchismus/Sondermann und Boehm - 2024 - Aktuelle Behandlungsstrategien des einfachen Maldeszensus testis.pdf:application/pdf},
}

@article{lowe_mariam_jahresruckblick_2024,
	title = {Jahresrückblick 24/{Jahresausblick} 25 - {Ausblick} auf {Fortbildungen} 2025},
	copyright = {All rights reserved},
	issn = {1869-6619},
	url = {https://uroforum.de},
	language = {Deutsch},
	number = {10/2024},
	journal = {UroForum},
	author = {Löwe, Mariam and Heinrichs, Anna and Sondermann, Marcus and Murnik, Markus and Chi Le, Quynh and Moharam, Nadim},
	month = nov,
	year = {2024},
	pages = {47},
}

@article{buerk_prognostic_2024,
	title = {Prognostic potential of standard laboratory parameters in patients with metastatic renal cell cancer receiving first-line immunotherapy},
	volume = {14},
	copyright = {All rights reserved},
	issn = {2045-2322},
	url = {https://www.nature.com/articles/s41598-024-76928-3},
	doi = {10.1038/s41598-024-76928-3},
	abstract = {Abstract
            Through their involvement in cancer metabolism, alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), γ-glutamyltransferase (GGT) and lactate dehydrogenase (LDH) reflect the tumor burden and thus could have a prognostic potential for patients treated with immune checkpoint inhibitors (CPI). Therefore, this study investigated the prognostic potential of these parameters in a real-world cohort of patients with metastatic renal cell cancer (mRCC) under first-line CPI-based therapy. The retrospective study cohort included 82 mRCC patients treated with CPI-based first-line therapy between 2019 and 2023. Progression-free survival (PFS), overall survival (OS) and response rates were evaluated according to baseline levels and early dynamic changes of ALAT, ASAT, GGT and LDH. Multivariate Cox proportional hazard regression models were generated to identify independent prognosticators for PFS and OS. High baseline levels and non-normalized kinetics of ALAT, ASAT, GGT and LDH were significantly associated with shorter PFS and OS (p {\textless} 0.05), which was also reflected by lower response rates. Combining the four parameters at baseline into a 4-Risk-Score resulted in an enhanced prognostic power, as indicated by a higher C-index of 0.693 for OS compared to the individual parameters (≤ 0.663). Patients with all four risk factors present showed the worst PFS and OS. Overall, baseline levels and early kinetics of the four parameters as well as the 4-Risk-Score were identified as independent prognosticators for PFS and OS by multivariate analysis. As standard laboratory parameters, ALAT, ASAT, GGT and LDH are cost-effective and could be easily used either alone or in combination for therapy monitoring of CPI-treated mRCC patients.},
	language = {en},
	number = {1},
	urldate = {2024-11-02},
	journal = {Scientific Reports},
	author = {Buerk, Bjoern Thorben and Kusiek, Cathrin and Schüttke, Vayda and Sondermann, Marcus and Yakac, Abdulbaki and Abbate, Elena and Fuessel, Susanne and Thomas, Christian and Erdmann, Kati},
	month = oct,
	year = {2024},
	pages = {25365},
	file = {Buerk et al. - 2024 - Prognostic potential of standard laboratory parameters in patients with metastatic renal cell cancer.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Urologie/Tumore/Niere/Buerk et al. - 2024 - Prognostic potential of standard laboratory parameters in patients with metastatic renal cell cancer.pdf:application/pdf},
}

@article{sondermann_kunstliche_2024,
	title = {Künstliche {Intelligenz} im {Tumorboard} – {Möglichkeiten}, {Chancen} und {Risken}},
	copyright = {All rights reserved},
	abstract = {Das urologische Tumorboard ermöglicht durch den multidisziplinären Austausch zwischen Urologen, Onkolo-
gen, Radiologen und anderen Fachdisziplinen eine verbesserte Diagnostik und Therapie für die Patienten. Die-
ser Prozess hat sich insbesondere im Rahmen der Zertifizierung weiter verstärkt. Trotz des erheblichen zeitli-
chen Aufwands zur Vor- und Nachbereitung ermöglicht das Tumorboard qualitativ hochwertige und individuell
zugeschnittene Behandlungsstrategien. Künstliche Intelligenz (KI) hat das Potenzial, die Effizienz von Tumor-
boards zu steigern, indem sie große Datenmengen analysiert und präzisere Diagnosen stellt.},
	number = {10/2024},
	journal = {UroForum},
	author = {Sondermann, Marcus and Mehralivand, Sherif},
	month = nov,
	year = {2024},
	file = {Sondermann und Mehralivand - 2024 - Künstliche Intelligenz im Tumorboard – Möglichkeiten, Chancen und Risken.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Urologie/AI/Sondermann und Mehralivand - 2024 - Künstliche Intelligenz im Tumorboard – Möglichkeiten, Chancen und Risken.pdf:application/pdf},
}

@article{telemann_machine_2024,
	title = {Machine {Learning}, ­ {KI} und {Deep} {Learning} im klinischen {Alltag} – worauf müssen wir uns vorbereiten und wie beeinflusst das die urolo- gische {Weiterbildung}?},
	volume = {63},
	copyright = {https://www.springernature.com/gp/researchers/text-and-data-mining},
	issn = {2731-7064, 2731-7072},
	url = {https://link.springer.com/10.1007/s00120-024-02451-y},
	doi = {10.1007/s00120-024-02451-y},
	language = {de},
	number = {10},
	urldate = {2024-11-06},
	journal = {Die Urologie},
	author = {Telemann, Lucie and Sondermann, Marcus},
	month = oct,
	year = {2024},
	pages = {1081--1082},
	file = {Telemann und Sondermann - 2024 - Machine Learning, ­ KI und Deep Learning im klinischen Alltag – worauf müssen wir uns vorbereiten un.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Urologie/AI/Telemann und Sondermann - 2024 - Machine Learning, ­ KI und Deep Learning im klinischen Alltag – worauf müssen wir uns vorbereiten un.pdf:application/pdf},
}

@article{sondermann_erfolgreiche_2024,
	title = {Erfolgreiche {Promotionsmodelle} für klinisch tätige Ä{rztInnen}},
	copyright = {All rights reserved},
	issn = {1869-6619},
	url = {https://uroforum.de},
	language = {Deutsch},
	number = {8/2024},
	journal = {UroForum},
	author = {Sondermann, Marcus and Hirtsiefer, Christopfer and Sondermann, Verena},
	month = oct,
	year = {2024},
	pages = {54--55},
}

@article{lowe_gesru_2024,
	title = {{GeSRU} {Jahresbericht} ­ 2024},
	volume = {63},
	copyright = {https://www.springernature.com/gp/researchers/text-and-data-mining},
	issn = {2731-7064, 2731-7072},
	url = {https://link.springer.com/10.1007/s00120-024-02485-2},
	doi = {10.1007/s00120-024-02485-2},
	language = {de},
	number = {12},
	urldate = {2025-01-08},
	journal = {Die Urologie},
	author = {Löwe,, Mariam and Chi Le, Quynh and Moharam, Nadim and Murnik, Markus and Heinrichs, Anna and Sondermann, Marcus},
	month = dec,
	year = {2024},
	pages = {1314--1315},
}

@article{sondermann_nierenzellkarzinom_2025,
	title = {Das {Nierenzellkarzinom}: {Aktuelle} {Therapiealgorithmen}},
	volume = {15},
	issn = {2198-5650, 2568-8251},
	shorttitle = {Das {Nierenzellkarzinom}},
	url = {https://econtent.hogrefe.com/doi/10.1024/2198-5650/a000023},
	doi = {10.1024/2198-5650/a000023},
	abstract = {Die Therapie des Nierenzellkarzinoms (RCC) ist stark stadienabhängig und umfasst chirurgische Ansätze, Systemtherapien und palliative Maßnahmen. Beim lokalisierten RCC steht die kurative operative Entfernung im Fokus, während in metastasierten Stadien eine Kombination aus Immun- und Tyrosinkinase-Inhibitoren sowie individuelle palliative Interventionen erfordern. Die adjuvante Therapie mit Checkpoint-Inhibitoren verbessert die Prognose bei Hochrisikopatienten signifikant. Systemtherapien orientieren sich an Prognosekriterien wie den IMDC-Scores und ermöglichen durch personalisierte Ansätze eine effektive Krankheitskontrolle. Palliative Maßnahmen wie Radiotherapie bei Metastasen oder supportive Therapien spielen eine entscheidende Rolle für die Lebensqualität der Betroffenen. Eine enge interdisziplinäre Zusammenarbeit und die Berücksichtigung individueller Patientenbedürfnisse sind essenziell für die optimale Betreuung.},
	language = {de},
	number = {1},
	urldate = {2025-04-06},
	journal = {Onkologische Pflege},
	author = {Sondermann, Marcus and Chi Le, Quynh and Kloft, Maximilian and Kalogirou, Charis},
	month = mar,
	year = {2025},
	pages = {35--40},
}

@article{menzel_urodynamik_2025,
	title = {Urodynamik in {Deutschland}: {Indikationen} und {Anwendung} im urologischen {Klinik}- und {Praxisalltag}},
	issn = {2731-7064, 2731-7072},
	shorttitle = {Urodynamik in {Deutschland}},
	url = {https://link.springer.com/10.1007/s00120-025-02579-5},
	doi = {10.1007/s00120-025-02579-5},
	abstract = {Zusammenfassung

              Hintergrund
              Urodynamische Studien (UDS) sind ein etabliertes Diagnostikverfahren in der Urologie. Internationale Studien, auch in Deutschland, zeigen jedoch einen Rückgang ihrer Anwendung. Gründe hierfür könnten Leitlinienanpassungen und veränderte Indikationsstellungen sein.


              Fragestellung
              Ziel ist es, die Versorgungsrealität und Indikationsverteilung für UDS in urologischen Kliniken und Praxen in Deutschland zu untersuchen.


              Material und Methoden
              Zwischen 03/2023 und 10/2023 wurden landesweit 259 urologische Kliniken und stichprobenartig 280 niedergelassene Urologen zur UDS befragt. Daten zu angewandten Methoden, durchführendem Personal und Indikationsverteilung wurden erhoben.


              Ergebnisse
              Es nahmen 80 \% der Kliniken und 44 \% der Praxen teil. 58 \% der Kliniken führen {\textless} 100 UDS pro Jahr durch. 15 \% der Praxen führen selbstständig UDS durch. Verfahren wie Uroflowmetrien (99 \%) und Zystomanometrien (98 \%) werden flächendeckend angewandt, während Videourodynamiken (53 \%) seltener zur Verfügung stehen. Häufigste Indikationen in Kliniken sind neurogene Blasenfunktionsstörungen (24 \%), überaktive Harnblasen (21 \%) und Belastungsinkontinenz bei Frauen (19 \%). Praxen zeigen ähnliche Schwerpunkte: neurogene Blasenfunktionsstörungen (30 \%) und überaktive Harnblasen (26 \%). Universitätskliniken und spezialisierte Zentren führen signifikant häufiger UDS bei komplexen Krankheiten durch, während die Versorgung der weiblichen Belastungsinkontinenz häufiger in nichtuniversitären Kliniken erfolgt.


              Schlussfolgerung
              Trotz sinkender Fallzahlen bleiben UDS zentral für die Diagnostik. Die Indikationsverteilung variiert je nach Kliniktyp. Diese Ergebnisse liefern Einblicke in die Praxisanwendung von UDS in Deutschland und unterstreichen ihre Rolle in der urologischen Diagnostik.


              Graphic abstract

          ,
            Abstract

              Background
              Urodynamic studies (UDS) are an established diagnostic tool in urology. However, international studies, including those from Germany, indicate a decline in their use. This trend may be attributed to guideline adjustments and changes in indications.


              Objective
              The study aims to analyse the current practice and distribution of indications for UDS in urological clinics and practices in Germany.


              Materials and methods
              Between March 2023 and October 2023, 259 urological clinics and a representative sample of 280 outpatient urologists nationwide were surveyed about their UDS procedures. Data on methods, personnel and indications were collected.


              Results
              In all, 80\% of clinics and 44\% of practices participated. 58\% of clinics performed fewer than 100 UDS annually. Only 15\% of practices performed UDS themselves. Common procedures such as uroflowmetry (99\%) and cystometry (98\%) are widely implemented, whereas video urodynamics (53\%) are less frequent. The most common indications in clinics are neurogenic bladder dysfunction (24\%), overactive bladder (21\%) and female stress incontinence (19\%). Practices showed similar trends, with neurogenic bladder dysfunction (30\%) and overactive bladder (26\%) as primary indications. University hospitals and specialized centres performed UDS more often for complex conditions, while non-university clinics frequently addressed stress incontinence.


              Conclusion
              Despite declining numbers, UDS remain central to urological diagnostics. Indication patterns vary by clinic type. These results provide insights into the application of UDS in Germany and underline its important role in urological diagnostics.},
	language = {de},
	urldate = {2025-04-15},
	journal = {Die Urologie},
	author = {Menzel, Viktoria and Kontschak, Livia and Sondermann, Marcus and Grabbert, Markus and Borkowetz, Angelika and Mehralivand, Sherif and Eisenmenger, Nicole and Huber, Johannes and Thomas, Christian and Schultz-Lampel, Daniela and Baunacke, Martin},
	month = apr,
	year = {2025},
}

@article{sondermann_veranderung_2025,
	title = {Veränderung des {Gesamtüberlebens} von {Patienten} mit {Nierenzellkarzinoms}},
	url = {https://edoc.rki.de/handle/176904/12718},
	doi = {10.25646/13119},
	abstract = {Die Therapie des Nierenzellkarzinoms hat sich sowohl im lokal fortgeschrittenen als auch metastasierten Stadium in den letzten Jahren durch die Einführung neuer OP-Techniken und Behandlungsregime deutlich verändert. Wissenschaftlich sollte sich daher die Überlebensdauer deutlich verbessert haben. Daher wollen wir anhand des Diagnosejahres und des individuellen Überlebens die Verbesserung dieser Therapie in der Praxis überprüfen.

 Ziel der geplanten Arbeit ist der Vergleich des relativen und absoluten Gesamtüberlebens bei Patienten mit Nierenzellkarzinom in Deutschland anhand der Daten des RKI-Krebsregisters. Subgruppenanalysen werden stratifiziert nach Alter bei Erstdiagnose, TNM-Stadium, Grading.
 Zur multivariaten Analyse dienen Alter bei Erstdiagnose, TNM-Stadium, Grading und das Diagnosejahr.
 Hierbei soll die Frage geklärt werden, ob es in den letzten Jahren eine Veränderung des relativen und absoluten Gesamtüberlebens und des Tumorspezifischen Überlebens gibt.},
	urldate = {2025-07-16},
	author = {Sondermann, Marcus},
	editor = {{Robert Koch-Institut}},
	collaborator = {Boehm, Katharina and Mehralivand, Sherif and Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Urologie},
	year = {2025},
	note = {Publisher: Robert Koch-Institut},
}

@article{hoeh_metastatic_2025,
	title = {Metastatic renal cell carcinoma: {Synchronous} vs. metachronous metastatic disease and its impact on cancer control in the {IO}-combination era—{Real} world experiences from a multi-institutional cohort},
	copyright = {https://www.elsevier.com/tdm/userlicense/1.0/},
	issn = {1078-1439},
	shorttitle = {Metastatic renal cell carcinoma},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S1078143925001322},
	doi = {10.1016/j.urolonc.2025.04.004},
	language = {en},
	urldate = {2025-07-26},
	journal = {Urologic Oncology: Seminars and Original Investigations},
	author = {Hoeh, Benedikt and Garcia, Cristina Cano and Mattigk, Angelika and Sondermann, Marcus and Klümper, Niklas and Cox, Alexander and Hahn, Oliver and Vollemaere, Jonathan and Erdmann, Kati and Schmucker, Philipp and Flegar, Luka and Zengerling, Friedemann and Banek, Severine and Ellinger, Jörg and Huber, Johannes and Zeuschner, Philip and Kalogirou, Charis},
	month = may,
	year = {2025},
	note = {Publisher: Elsevier BV},
}

@article{lowe_gesru_2025,
	title = {{GeSRU} {Angebote} im {Rahmen} der {Regionalkongresse} ­ 2025},
	volume = {64},
	copyright = {https://www.springernature.com/gp/researchers/text-and-data-mining},
	issn = {2731-7064, 2731-7072},
	url = {https://link.springer.com/10.1007/s00120-025-02548-y},
	doi = {10.1007/s00120-025-02548-y},
	language = {de},
	number = {3},
	urldate = {2025-07-26},
	journal = {Die Urologie},
	author = {Löwe, Mariam and Chi Le, Quynh and Moharam, Nadim and Murnik, Markus and Heinrichs, Anna and Sondermann, Marcus},
	month = mar,
	year = {2025},
	note = {Publisher: Springer Science and Business Media LLC},
	pages = {320--321},
}

@article{sondermann_machine_2025,
	series = {{BJUI} {Compass}},
	title = {A {Machine} {Learning} {Algorithm} for {Automatic} {Tumor} {Board} {Recommendations} in {Prostate} {Cancer} {Patients}},
	doi = {10.1002/bco2.70066},
	language = {English},
	journal = {BJUI Compass},
	author = {Sondermann, Marcus and Glaser, Hannah and Rentsch, Anke and Boehm, Katharina and Herout, Roman and Hölscher, Tobias and Lohaus, Fabian and Funer, Fabian and Miederer, Matthias and Thomas, Christian and Mehralivand, Sherif},
	month = sep,
	year = {2025},
	file = {Sondermann et al. - 2025 - A Machine Learning Algorithm for Automatic Tumor Board Recommendations in Prostate Cancer Patients.pdf:/Users/marcussondermann/Library/CloudStorage/OneDrive-Persönlich/Dokumente/Arbeit/Quellen/Urologie/AI/Methods/Sondermann et al. - 2025 - A Machine Learning Algorithm for Automatic Tumor Board Recommendations in Prostate Cancer Patients.pdf:application/pdf},
}
